type 2 diabetes

  1. forestglip

    SGLT2 inhibitors prevent long-COVID-associated cognitive and pain symptoms in type 2 diabetes patients, 2025, Yeh et al

    SGLT2 inhibitors prevent long-COVID-associated cognitive and pain symptoms in type 2 diabetes patients Background Long COVID presents significant health challenges, especially for patients with type 2 diabetes. Emerging evidence suggests that sodium-glucose cotransporter-2 (SGLT2) inhibitors...
  2. forestglip

    [COVID-19] Pandemic is Associated with a Substantial Rise in Frequency and Severity of Presentation of Youth-Onset Type 2 Diabetes, 2022, Magge et al

    The Coronavirus Disease 2019 Pandemic is Associated with a Substantial Rise in Frequency and Severity of Presentation of Youth-Onset Type 2 Diabetes Published: 2022 [Line breaks added] Objectives: To evaluate the frequency and severity of new cases of youth-onset...
  3. forestglip

    HbA1c and leukocyte mtDNA levels as major factors associated with post-COVID-19 syndrome in type 2 diabetes patients, 2024, Matviichuk et al

    HbA1c and leukocyte mtDNA levels as major factors associated with post-COVID-19 syndrome in type 2 diabetes patients Anton Matviichuk, Viktoriia Yerokhovych, Yeva Ilkiv, Dmytro Krasnienkov, Veronika Korcheva, Oleksandr Gurbych, Anna Shcherbakova, Pavlina Botsun, Tetyana Falalyeyeva, Oksana...
  4. Wyva

    Multiple Early Factors Anticipate Post-Acute COVID-19 Sequelae, 2022, Su et al

    Highlights Longitudinal multiomics associate PASC with autoantibodies, viremia and comorbidities Reactivation of latent viruses during initial infection may contribute to PASC Subclinical autoantibodies negatively correlate with anti-SARS-CoV-2 antibodies Gastrointestinal PASC uniquely present...
    • Wyva
    • Thread
    • anxiety autoantibodies cortisol covid-19 depression diabetes ebv epstein-barr long covid risk factors study type 2 diabetes
    • Replies: 6
    • Forum: Long Covid research
Back
Top Bottom